Insider Transactions in Q2 2022 at Aclaris Therapeutics, Inc. (ACRS)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 17
2022
|
Andrew N Schiff |
SELL
Open market or private sale
|
Direct |
19,565
-100.0%
|
$293,475
$15.14 P/Share
|
|
Jun 03
2022
|
Maxine Gowen |
BUY
Exercise of conversion of derivative security
|
Direct |
3,356
+30.1%
|
-
|
|
Jun 03
2022
|
William D. Humphries |
BUY
Exercise of conversion of derivative security
|
Direct |
3,356
+14.64%
|
-
|
|
Jun 03
2022
|
Anand Mehra |
BUY
Exercise of conversion of derivative security
|
Direct |
3,356
+8.94%
|
-
|
|
Jun 03
2022
|
Vincent Milano |
BUY
Exercise of conversion of derivative security
|
Direct |
3,356
+50.0%
|
-
|
|
Jun 03
2022
|
Christopher P. Molineaux |
BUY
Exercise of conversion of derivative security
|
Direct |
3,356
+10.97%
|
-
|
|
Jun 03
2022
|
Andrew Kenneth William Powell |
BUY
Exercise of conversion of derivative security
|
Direct |
3,356
+19.5%
|
-
|
|
Jun 03
2022
|
Bryan M. Reasons |
BUY
Exercise of conversion of derivative security
|
Direct |
3,356
+14.64%
|
-
|
|
Jun 03
2022
|
Andrew N Schiff |
BUY
Exercise of conversion of derivative security
|
Direct |
3,356
+14.64%
|
-
|
|
May 16
2022
|
Andrew Kenneth William Powell |
SELL
Bona fide gift
|
Direct |
709
-6.33%
|
-
|
|
Apr 25
2022
|
Neal Walker INTERIM CEO |
SELL
Open market or private sale
|
Direct |
20,000
-1.58%
|
$300,000
$15.18 P/Share
|
|
Apr 22
2022
|
Neal Walker INTERIM CEO |
SELL
Open market or private sale
|
Direct |
25,000
-1.94%
|
$375,000
$15.04 P/Share
|
|
Apr 21
2022
|
Neal Walker INTERIM CEO |
SELL
Open market or private sale
|
Direct |
25,000
-1.9%
|
$375,000
$15.24 P/Share
|
|
Apr 18
2022
|
Joseph Monahan Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
30,000
-22.0%
|
$480,000
$16.28 P/Share
|